English
简体中文
Total: £ 56.28
Published Date: 2026-04-02 | Pages: 110 | Tables: 102 | Medical Care
The global Skin Microbiome Modulator market was valued at US$ 903 million in 2025 and is anticipated to reach US$ 2205 million by 2032, at a CAGR of 13.8% from 2026 to 2032.
Skin microbiome regulators refer to a class of functional substances or products that maintain or restore the balance of skin microecology by regulating the composition, structure and metabolic activity of the microbial community on the skin surface, thereby improving or enhancing the health of the skin. Such regulators include probiotics, prebiotics, postbiotics, microecological metabolites, natural plant extracts, etc., which can promote the growth of beneficial bacteria, inhibit pathogenic microorganisms, enhance skin barrier function and regulate immune response. They are suitable for multiple skin care fields such as anti-inflammatory, anti-allergic, anti-acne, and anti-aging. With the in-depth understanding of the relationship between skin microecology and skin diseases, skin microbiome regulators have become an important direction of modern dermatology, cosmetic development and personalized skin care, and have been widely used in medical skin care and functional cosmetics.
Skin microbiome regulators are gradually becoming an emerging focus in the field of skin care technology. They help maintain or restore the balance of the microecology by regulating the microbial community on the surface of the skin, thereby improving the skin barrier function and overall health. At present, such regulators can be mainly divided into three categories: probiotics (such as active microorganisms such as Lactobacillus and Staphylococcus epidermidis), which can directly act on the skin microecology; prebiotics (such as oligofructose, inulin, etc.), which promote the reproduction and colonization of beneficial bacteria by providing nutrition for them; and pharmaceutical regulators, including antimicrobial peptides, microecological targeting molecules, etc., are more used to specifically inhibit pathogenic bacteria or regulate immune responses. These regulators have been widely used in skin care products (such as anti-inflammatory, anti-acne, anti-allergic, and moisturizing facial skin care products), hair care products (such as scalp soothing, oil control, and anti-hair loss products), and gradually expanded to "other" high-potential scenarios such as medical-assisted skin care, infant care, men's care, and postoperative repair.
The core manufacturers of global skin microbiome regulators include L’Oréal S.A., Unilever and The Estée Lauder Companies, etc. The top three manufacturers account for about 27% of the global market share. The Americas is the world's largest market, accounting for about 33% of the market share, followed by Asia Pacific and Europe, accounting for 32% and 26% respectively.
With the deepening integration of microbiome, synthetic biology and skin science, skin microbiome regulators will develop in a more precise, personalized and intelligent direction in the future. For example, customizing personalized regulation plans through AI analysis of individual skin microecological status, or developing a controlled release live bacteria delivery system, will become a breakthrough in the industry. At the same time, with the increase in consumers' dual demands for "effective skin care" and "natural safety", regulator products must also take into account scientific verification and green sustainability.
In this wave of development, manufacturers should actively change their roles from a simple raw material supplier to a microecological solution provider. On the one hand, we should increase basic research on the skin microecological mechanism, flora interaction, and regulator efficacy mechanism, and promote clinical efficacy verification and the construction of a standardized evaluation system; on the other hand, we should explore diversified product forms (such as freeze-dried powder, encapsulated microcapsules, and instant activation preparations) to improve ease of use and ingredient stability. In addition, manufacturers should also pay attention to regulatory trends and industry standard formulation, strengthen cooperation with brand owners and scientific research institutions, lay out intellectual property and patent pools, build new competitive advantages with microecological skin care as the core, and promote the true transformation of skin microbiome regulators from technical concepts to large-scale product markets.
This report delivers a comprehensive overview of the global Skin Microbiome Modulator market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Skin Microbiome Modulator. The Skin Microbiome Modulator market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Skin Microbiome Modulator market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Skin Microbiome Modulator manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
L'Oréal
Unilever
The Estée Lauder Companies
Johnson & Johnson
Revlon
Evelo Biosciences
AOBiome
Azitra
GALLINÉE
Glowbiotics
Segment by Type
Probiotics
Prebiotics
Drugs
Segment by Application
Skin Care
Hair Care
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Skin Microbiome Modulator companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Skin Microbiome Modulator Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Probiotics
1.2.3 Prebiotics
1.2.4 Drugs
1.3 Market by Application
1.3.1 Global Skin Microbiome Modulator Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Skin Care
1.3.3 Hair Care
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Skin Microbiome Modulator Market Perspective (2021–2032)
2.2 Global Skin Microbiome Modulator Growth Trends by Region
2.2.1 Global Skin Microbiome Modulator Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Skin Microbiome Modulator Historic Market Size by Region (2021–2026)
2.2.3 Skin Microbiome Modulator Forecasted Market Size by Region (2027–2032)
2.3 Skin Microbiome Modulator Market Dynamics
2.3.1 Skin Microbiome Modulator Industry Trends
2.3.2 Skin Microbiome Modulator Market Drivers
2.3.3 Skin Microbiome Modulator Market Challenges
2.3.4 Skin Microbiome Modulator Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Skin Microbiome Modulator Players by Revenue
3.1.1 Global Top Skin Microbiome Modulator Players by Revenue (2021–2026)
3.1.2 Global Skin Microbiome Modulator Revenue Market Share by Players (2021–2026)
3.2 Global Top Skin Microbiome Modulator Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Skin Microbiome Modulator Revenue
3.4 Global Skin Microbiome Modulator Market Concentration Ratio
3.4.1 Global Skin Microbiome Modulator Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Skin Microbiome Modulator Revenue in 2025
3.5 Global Key Players of Skin Microbiome Modulator Head Offices and Areas Served
3.6 Global Key Players of Skin Microbiome Modulator, Products and Applications
3.7 Global Key Players of Skin Microbiome Modulator, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Skin Microbiome Modulator Breakdown Data by Type
4.1 Global Skin Microbiome Modulator Historic Market Size by Type (2021–2026)
4.2 Global Skin Microbiome Modulator Forecasted Market Size by Type (2027–2032)
5 Skin Microbiome Modulator Breakdown Data by Application
5.1 Global Skin Microbiome Modulator Historic Market Size by Application (2021–2026)
5.2 Global Skin Microbiome Modulator Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Skin Microbiome Modulator Market Size (2021–2032)
6.2 North America Skin Microbiome Modulator Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Skin Microbiome Modulator Market Size by Country (2021–2026)
6.4 North America Skin Microbiome Modulator Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Skin Microbiome Modulator Market Size (2021–2032)
7.2 Europe Skin Microbiome Modulator Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Skin Microbiome Modulator Market Size by Country (2021–2026)
7.4 Europe Skin Microbiome Modulator Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Skin Microbiome Modulator Market Size (2021–2032)
8.2 Asia-Pacific Skin Microbiome Modulator Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Skin Microbiome Modulator Market Size by Region (2021–2026)
8.4 Asia-Pacific Skin Microbiome Modulator Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Skin Microbiome Modulator Market Size (2021–2032)
9.2 Latin America Skin Microbiome Modulator Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Skin Microbiome Modulator Market Size by Country (2021–2026)
9.4 Latin America Skin Microbiome Modulator Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Skin Microbiome Modulator Market Size (2021–2032)
10.2 Middle East & Africa Skin Microbiome Modulator Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Skin Microbiome Modulator Market Size by Country (2021–2026)
10.4 Middle East & Africa Skin Microbiome Modulator Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 L'Oréal
11.1.1 L'Oréal Company Details
11.1.2 L'Oréal Business Overview
11.1.3 L'Oréal Skin Microbiome Modulator Introduction
11.1.4 L'Oréal Revenue in Skin Microbiome Modulator Business (2021–2026)
11.1.5 L'Oréal Recent Development
11.2 Unilever
11.2.1 Unilever Company Details
11.2.2 Unilever Business Overview
11.2.3 Unilever Skin Microbiome Modulator Introduction
11.2.4 Unilever Revenue in Skin Microbiome Modulator Business (2021–2026)
11.2.5 Unilever Recent Development
11.3 The Estée Lauder Companies
11.3.1 The Estée Lauder Companies Company Details
11.3.2 The Estée Lauder Companies Business Overview
11.3.3 The Estée Lauder Companies Skin Microbiome Modulator Introduction
11.3.4 The Estée Lauder Companies Revenue in Skin Microbiome Modulator Business (2021–2026)
11.3.5 The Estée Lauder Companies Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Skin Microbiome Modulator Introduction
11.4.4 Johnson & Johnson Revenue in Skin Microbiome Modulator Business (2021–2026)
11.4.5 Johnson & Johnson Recent Development
11.5 Revlon
11.5.1 Revlon Company Details
11.5.2 Revlon Business Overview
11.5.3 Revlon Skin Microbiome Modulator Introduction
11.5.4 Revlon Revenue in Skin Microbiome Modulator Business (2021–2026)
11.5.5 Revlon Recent Development
11.6 Evelo Biosciences
11.6.1 Evelo Biosciences Company Details
11.6.2 Evelo Biosciences Business Overview
11.6.3 Evelo Biosciences Skin Microbiome Modulator Introduction
11.6.4 Evelo Biosciences Revenue in Skin Microbiome Modulator Business (2021–2026)
11.6.5 Evelo Biosciences Recent Development
11.7 AOBiome
11.7.1 AOBiome Company Details
11.7.2 AOBiome Business Overview
11.7.3 AOBiome Skin Microbiome Modulator Introduction
11.7.4 AOBiome Revenue in Skin Microbiome Modulator Business (2021–2026)
11.7.5 AOBiome Recent Development
11.8 Azitra
11.8.1 Azitra Company Details
11.8.2 Azitra Business Overview
11.8.3 Azitra Skin Microbiome Modulator Introduction
11.8.4 Azitra Revenue in Skin Microbiome Modulator Business (2021–2026)
11.8.5 Azitra Recent Development
11.9 GALLINÉE
11.9.1 GALLINÉE Company Details
11.9.2 GALLINÉE Business Overview
11.9.3 GALLINÉE Skin Microbiome Modulator Introduction
11.9.4 GALLINÉE Revenue in Skin Microbiome Modulator Business (2021–2026)
11.9.5 GALLINÉE Recent Development
11.10 Glowbiotics
11.10.1 Glowbiotics Company Details
11.10.2 Glowbiotics Business Overview
11.10.3 Glowbiotics Skin Microbiome Modulator Introduction
11.10.4 Glowbiotics Revenue in Skin Microbiome Modulator Business (2021–2026)
11.10.5 Glowbiotics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Skin Microbiome Modulator Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Probiotics
Table 3. Key Players of Prebiotics
Table 4. Key Players of Drugs
Table 5. Global Skin Microbiome Modulator Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Skin Microbiome Modulator Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Skin Microbiome Modulator Market Size by Region (US$ Million), 2021–2026
Table 8. Global Skin Microbiome Modulator Market Share by Region (2021–2026)
Table 9. Global Skin Microbiome Modulator Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Skin Microbiome Modulator Market Share by Region (2027–2032)
Table 11. Skin Microbiome Modulator Market Trends
Table 12. Skin Microbiome Modulator Market Drivers
Table 13. Skin Microbiome Modulator Market Challenges
Table 14. Skin Microbiome Modulator Market Restraints
Table 15. Global Skin Microbiome Modulator Revenue by Players (US$ Million), 2021–2026
Table 16. Global Skin Microbiome Modulator Market Share by Players (2021–2026)
Table 17. Global Top Skin Microbiome Modulator Players by Tier (Tier 1, Tier 2, and Tier 3), based on Skin Microbiome Modulator Revenue, 2025
Table 18. Ranking of Global Top Skin Microbiome Modulator Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Skin Microbiome Modulator Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Skin Microbiome Modulator, Headquarters and Area Served
Table 21. Global Key Players of Skin Microbiome Modulator, Products and Applications
Table 22. Global Key Players of Skin Microbiome Modulator, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Skin Microbiome Modulator Market Size by Type (US$ Million), 2021–2026
Table 25. Global Skin Microbiome Modulator Revenue Market Share by Type (2021–2026)
Table 26. Global Skin Microbiome Modulator Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Skin Microbiome Modulator Revenue Market Share by Type (2027–2032)
Table 28. Global Skin Microbiome Modulator Market Size by Application (US$ Million), 2021–2026
Table 29. Global Skin Microbiome Modulator Revenue Market Share by Application (2021–2026)
Table 30. Global Skin Microbiome Modulator Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Skin Microbiome Modulator Revenue Market Share by Application (2027–2032)
Table 32. North America Skin Microbiome Modulator Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Skin Microbiome Modulator Market Size by Country (US$ Million), 2021–2026
Table 34. North America Skin Microbiome Modulator Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Skin Microbiome Modulator Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Skin Microbiome Modulator Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Skin Microbiome Modulator Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Skin Microbiome Modulator Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Skin Microbiome Modulator Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Skin Microbiome Modulator Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Skin Microbiome Modulator Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Skin Microbiome Modulator Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Skin Microbiome Modulator Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Skin Microbiome Modulator Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Skin Microbiome Modulator Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Skin Microbiome Modulator Market Size by Country (US$ Million), 2027–2032
Table 47. L'Oréal Company Details
Table 48. L'Oréal Business Overview
Table 49. L'Oréal Skin Microbiome Modulator Product
Table 50. L'Oréal Revenue in Skin Microbiome Modulator Business (US$ Million), 2021–2026
Table 51. L'Oréal Recent Development
Table 52. Unilever Company Details
Table 53. Unilever Business Overview
Table 54. Unilever Skin Microbiome Modulator Product
Table 55. Unilever Revenue in Skin Microbiome Modulator Business (US$ Million), 2021–2026
Table 56. Unilever Recent Development
Table 57. The Estée Lauder Companies Company Details
Table 58. The Estée Lauder Companies Business Overview
Table 59. The Estée Lauder Companies Skin Microbiome Modulator Product
Table 60. The Estée Lauder Companies Revenue in Skin Microbiome Modulator Business (US$ Million), 2021–2026
Table 61. The Estée Lauder Companies Recent Development
Table 62. Johnson & Johnson Company Details
Table 63. Johnson & Johnson Business Overview
Table 64. Johnson & Johnson Skin Microbiome Modulator Product
Table 65. Johnson & Johnson Revenue in Skin Microbiome Modulator Business (US$ Million), 2021–2026
Table 66. Johnson & Johnson Recent Development
Table 67. Revlon Company Details
Table 68. Revlon Business Overview
Table 69. Revlon Skin Microbiome Modulator Product
Table 70. Revlon Revenue in Skin Microbiome Modulator Business (US$ Million), 2021–2026
Table 71. Revlon Recent Development
Table 72. Evelo Biosciences Company Details
Table 73. Evelo Biosciences Business Overview
Table 74. Evelo Biosciences Skin Microbiome Modulator Product
Table 75. Evelo Biosciences Revenue in Skin Microbiome Modulator Business (US$ Million), 2021–2026
Table 76. Evelo Biosciences Recent Development
Table 77. AOBiome Company Details
Table 78. AOBiome Business Overview
Table 79. AOBiome Skin Microbiome Modulator Product
Table 80. AOBiome Revenue in Skin Microbiome Modulator Business (US$ Million), 2021–2026
Table 81. AOBiome Recent Development
Table 82. Azitra Company Details
Table 83. Azitra Business Overview
Table 84. Azitra Skin Microbiome Modulator Product
Table 85. Azitra Revenue in Skin Microbiome Modulator Business (US$ Million), 2021–2026
Table 86. Azitra Recent Development
Table 87. GALLINÉE Company Details
Table 88. GALLINÉE Business Overview
Table 89. GALLINÉE Skin Microbiome Modulator Product
Table 90. GALLINÉE Revenue in Skin Microbiome Modulator Business (US$ Million), 2021–2026
Table 91. GALLINÉE Recent Development
Table 92. Glowbiotics Company Details
Table 93. Glowbiotics Business Overview
Table 94. Glowbiotics Skin Microbiome Modulator Product
Table 95. Glowbiotics Revenue in Skin Microbiome Modulator Business (US$ Million), 2021–2026
Table 96. Glowbiotics Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Skin Microbiome Modulator Picture
Figure 2. Global Skin Microbiome Modulator Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Skin Microbiome Modulator Market Share by Type: 2025 vs 2032
Figure 4. Probiotics Features
Figure 5. Prebiotics Features
Figure 6. Drugs Features
Figure 7. Global Skin Microbiome Modulator Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Skin Microbiome Modulator Market Share by Application: 2025 vs 2032
Figure 9. Skin Care Case Studies
Figure 10. Hair Care Case Studies
Figure 11. Others Case Studies
Figure 12. Skin Microbiome Modulator Report Years Considered
Figure 13. Global Skin Microbiome Modulator Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Skin Microbiome Modulator Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Skin Microbiome Modulator Market Share by Region: 2025 vs 2032
Figure 16. Global Skin Microbiome Modulator Market Share by Players in 2025
Figure 17. Global Skin Microbiome Modulator Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Skin Microbiome Modulator Revenue in 2025
Figure 19. North America Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Skin Microbiome Modulator Market Share by Country (2021–2032)
Figure 21. United States Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Skin Microbiome Modulator Market Share by Country (2021–2032)
Figure 25. Germany Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Skin Microbiome Modulator Market Share by Region (2021–2032)
Figure 33. China Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Skin Microbiome Modulator Market Share by Country (2021–2032)
Figure 41. Mexico Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Skin Microbiome Modulator Market Share by Country (2021–2032)
Figure 45. Israel Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Skin Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. L'Oréal Revenue Growth Rate in Skin Microbiome Modulator Business (2021–2026)
Figure 49. Unilever Revenue Growth Rate in Skin Microbiome Modulator Business (2021–2026)
Figure 50. The Estée Lauder Companies Revenue Growth Rate in Skin Microbiome Modulator Business (2021–2026)
Figure 51. Johnson & Johnson Revenue Growth Rate in Skin Microbiome Modulator Business (2021–2026)
Figure 52. Revlon Revenue Growth Rate in Skin Microbiome Modulator Business (2021–2026)
Figure 53. Evelo Biosciences Revenue Growth Rate in Skin Microbiome Modulator Business (2021–2026)
Figure 54. AOBiome Revenue Growth Rate in Skin Microbiome Modulator Business (2021–2026)
Figure 55. Azitra Revenue Growth Rate in Skin Microbiome Modulator Business (2021–2026)
Figure 56. GALLINÉE Revenue Growth Rate in Skin Microbiome Modulator Business (2021–2026)
Figure 57. Glowbiotics Revenue Growth Rate in Skin Microbiome Modulator Business (2021–2026)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
